Bilihome launches crowdfunding campaign – invest in impact

After pitching at the Business Angels Network Nijmegen (BANN), Bilihome is now taking the next big step: transitioning from a research-focused startup to a commercial MedTech company.

To fuel this growth, Bilihome has launched its first crowd-financing campaign, aiming to raise €2 to €5 million. With €1.2 million already committed by anchor investors such as OostNL and Health Innovations, there’s strong confidence in the company’s potential.

Bilihome is redefining newborn jaundice care by enabling zero-separation treatment—allowing babies to stay with their parents during therapy. This is your chance to invest in impact and innovation, with a potential 4–5x return on investment.

• Help make this breakthrough widely available.
• Support family-centered care.
• Invest now in Bilihome.

Find here the link to invesor’s platform.